O'Melveny & Myers

    September 02, 2007 | BY

    clpstaff &clp articles

    WuXi PharmaTech, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, has made its US$212 million initial…

    Share:

    WuXi PharmaTech, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, has made its US$212 million initial public offering on the New York Stock Exchange. The offering consisted